| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 135680-82-9 | Cyclo(L-Arginyl-L-Prolyl-L-a-aspartyl-D-Valyl-L-Tyrosyl)(9CI); 1H-Pyrrolo[1,2-a][1,4,7,10,13]pentaazacyclopentadecine,cyclic peptide deriv. |  | C29H42N8O8 | 详情 | 供应商 | |
| 34273-10-4 | 肌丙抗增压素; 1-肌氨酸-8-丙氨酸-血管紧张肽Ⅱ | L-Alanine,N-methylglycyl-L-Arginyl-L-Valyl-L-Tyrosyl-L-Valyl-L-histidyl-L-Prolyl-; AngiotensinII, 1-(N-methylglycine)-5-L-Valine-8-L-alanine-; Angiotensin II,1-sarcosine-5-L-Valine-8-L-alanine- (8CI); 1-Sar-5-Val-8-Ala-angiotensin II; 1-Sar-8-ala-angiotensin II; Aralasin; P 113; P 113 (angiotensin II derivative); Saralasin; [1-Sarcosine-5-Valine-8-alanine]angiotensin II |  | C42H65N13O10 | 详情 | 供应商 |
| 126985-97-5 | L-Argininamide,glycyl-L-Prolyl-L-serylglycyl-L-phenylalanyl-L-Tyrosylglycyl-L-Valyl-; LocustatachykininI; Lom-TK I |  | C43H63N13O11 | 详情 | 供应商 | |
| 118060-90-5 | L-Arginine,L-Tyrosyl-L-glutaminyl-L-glutaminyl-L-Prolyl-L-Valyl-L-leucylglycyl-L-Prolyl-L-Valyl-; L-Arginine,N2-[N-[1-[N-[N-[N-[1-[N2-(N2-L-Tyrosyl-L-glutaminyl)-L-glutaminyl]-L-Prolyl]-L-Valyl]-L-leucyl]glycyl]-L-Prolyl]-L-Valyl]-; 5: PN: CN1566152 PAGE: 4 unclaimed sequence; b-Casokinin-10; b-Casokinin-10 (ox) |  | C53H85N15O14 | 详情 | 供应商 | |
| 132309-70-7 | L-Argininamide,L-alanyl-L-Prolyl-L-glutaminyl-L-alanylglycyl-L-phenylalanyl-L-Tyrosylglycyl-L-Valyl-; LocustatachykininIII; Lom-TK III |  | C49H73N15O12 | 详情 | 供应商 | |
| 126985-98-6 | L-Argininamide,L-alanyl-L-Prolyl-L-leucyl-L-serylglycyl-L-phenylalanyl-L-Tyrosylglycyl-L-Valyl-; LocustatachykininII; Lom-TK II |  | C50H76N14O12 | 详情 | 供应商 | |
| 37827-06-8 | L-Isoleucine,N-methylglycyl-L-Arginyl-L-Valyl-L-Tyrosyl-L-isoleucyl-L-histidyl-L-Prolyl-; AngiotensinII, 1-(N-methylglycine)-5-L-isoleucine-8-L-isoleucine-; Angiotensin IIIinhibitor (human), N2-(N-methylglycyl)- (9CI); Sarilesin; [Sar1-Ile5-Ile8]-angiotensin II; [Sarcosyl1-Ile5-Ile8]-angiotensin II |  | C46H73N13O10 | 详情 | 供应商 | |
| 60063-06-1 | L-Proline,L-lysyl-L-lysyl-L-Arginyl-L-Arginyl-L-Prolyl-L-Valyl-L-lysyl-L-Valyl-L-Tyrosyl-; L-Proline,1-[N-[N-[N2-[N-[1-[N2-[N2-(N2-L-lysyl-L-lysyl)-L-Arginyl]-L-Arginyl]-L-Prolyl]-L-Valyl]-L-lysyl]-L-Valyl]-L-Tyrosyl]-; 15-24-ACTH |  | C59H103N19O12 | 详情 | 供应商 | |
| 74127-89-2 | L-Threonine,N-methylglycyl-L-Arginyl-L-Valyl-L-Tyrosyl-L-Valyl-L-histidyl-L-Prolyl- (9CI); AngiotensinII, 1-(N-methylglycine)-5-L-Valine-8-L-threonine-; Thr8-saralasin |  | C43H67N13O11 | 详情 | 供应商 | |
| 122299-11-0 | L-Tyrosine,L-seryl-L-Prolyl-L-Valyl-L-threonyl-L-leucyl-L-a-aspartyl-L-leucyl-L-Arginyl-; L-Tyrosine,N-[N2-[N-[N-[N-[N-[N-(1-L-seryl-L-Prolyl)-L-Valyl]-L-threonyl]-L-leucyl]-L-a-aspartyl]-L-leucyl]-L-Arginyl]- |  | C48H78N12O15 | 详情 | 供应商 | |
| 75808-67-2 | L-Phenylalanine,L-Valyl-L-Valyl-L-Tyrosyl-L-Prolyl-L-tryptophyl-L-threonyl-L-glutaminyl-L-Arginyl-; L-Phenylalanine,N-[N2-[N2-[N-[N-[1-[N-(N-L-Valyl-L-Valyl)-L-Tyrosyl]-L-Prolyl]-L-tryptophyl]-L-threonyl]-L-glutaminyl]-L-Arginyl]-; 11: PN: WO02063305 SEQID: 3 unclaimed sequence; 15: PN: DE10133576 SEQID: 15claimed Protein; 1: PN: CN101210047 SEQID: 1 claimed sequence; 29: PN:WO03011304 TABLE: 2 claimed Protein; 2: PN: US20030219447 TABLE: A claimedsequence; 2: PN: WO03006492 SEQID: 2 claimed Protein; 2: PN: WO2004055042SEQID: 2 claimed Protein; 68: PN: WO2005116051 SEQID: 68 claimed sequence; 86:PN: US20090004213 SEQID: 86 unclaimed sequence; 8: PN: WO2007024946 SEQID: 8unclaimed sequence; VV-haemorphin-7; VV-hemorphin-7; VVH-7 |  | C59H82N14O13 | 详情 | 供应商 | |
| 53632-49-8 | L-Threonine,N-methylglycyl-L-Arginyl-L-Valyl-L-Tyrosyl-L-isoleucyl-L-histidyl-L-Prolyl-; AngiotensinII, 1-(N-methylglycine)-5-L-isoleucine-8-L-threonine-; 159: PN: WO02064734SEQID: 159 claimed Protein; Sarthran; [Sar1,Ile5,Thr8]-angiotensin II |  | C44H69N13O11 | 详情 | 供应商 | |
| 157171-96-5 | L-Argininamide,5-oxo-L-Prolyl-L-Tyrosylglycyl-L-phenylalanyl-L-histidyl-L-alanyl-L-Valyl-(9CI); Anodontatachykinin; Anc-TK; Anodontatachykinin (Anodonta cygnea); Tachykinin (Anodonta cygnea) |  | C45H62N14O10 | 详情 | 供应商 | |
| 166090-74-0 | H-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA-OH | H-ASP-ALA-GLU-PHE-Arg-HIS-ASP-SER-GLY-Tyr-GLU-Val-HIS-HIS-GLN-LYS-LEU-Val-PHE-PHE-ALA-GLU-ASP-Val-GL; PREDOMINANT AMYLOID B-ProTEIN FRAGMENT; ASP-ALA-GLU-PHE-Arg-HIS-ASP-SER-GLY-Tyr-GLU-Val-HIS-HIS-GLN-LYS-LEU-Val-PHE-PHE-ALA-GLU-ASP-Val-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-MET-Val-GLY-GLY-Val-Val-ILE-ALA; ASP-ALA-GLU-PHE-GLY-HIS-ASP-SER-GLY-PHE-GLU-Val-Arg-HIS-GLN-LYS-LEU-Val-PHE-PHE-ALA-GLU-ASP-Val-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-MET-Val-GLY-GLY-Val-Val-ILE-ALA; BAP 1-42; BETA-AMYLOID, SODIUM SALT; BETA-AMYLOID PEPTIDE (1-40), MOUSE, RAT; BETA-AMYLOID PEPTIDE (1-40), RAT; BETA-AMYLOID PEPTIDE (1-42), RAT | 无 | C203H311N55O60S | 详情 | 供应商 |
| 64315-16-8 | 血管紧张素原 | ANGIOTENSINOGEN; H-ASP-Arg-Val-Tyr-ILE-HIS-Pro-PHE-HIS-LEU-LEU-Val-Tyr-SER-OH; ASP-Arg-Val-Tyr-ILE-HIS-Pro-PHE-HIS-LEU-LEU-Val-Tyr-SER; ANGIOTENSINOGEN FRAGMENT 1-14 PORCINE; ANGIOTENSINOGEN (1-14), PORCINE; ANGIOTENSINOGEN (1-14) (HORSE); ANGIOTENSINOGEN; PREANGIOTENSINOGEN (1-14) (HORSE); RENIN SUBSTRATE |  | C85H123N21O20 | 详情 | 供应商 |
| 68521-88-0 | 血管紧张素II | ASP-Arg-Val-Tyr-ILE-HIS-Pro-PHE ACETATE SALT; ANGIOTENSIN II ACETATE SALT; ANGIOTENSIN II HUMAN ACETATE SALT; ASP-Arg-Val-Tyr-ILE-HIS-Pro-PHE ACETATE SALT; HYPERTENSIN II; ANGIOTENSIN II, MASS SPEC STANDARD; ANGIOTENSIN II, HUMAN, SYNTHETIC; ANGIOTENSIN II ACETATE HUMAN; ANGIOTENSIN II-FLUORESCEIN SYNTHETIC >81 % |  | C52H75N13O14 | 详情 | 供应商 |
| 86879-15-4 | ASN-Arg-Val-Tyr-Val-HIS-Pro-PHE-ASN-LEU | ASN-Arg-Val-Tyr-Val-HIS-Pro-PHE-ASN-LEU; ANTI-COAGULANT ENZYME; ANGIOTENSIN I (SALMON); ANGIOTENSIN I; ANGIOTENSIN I (BULLFROG) (Val5, ASN8); (ASN1,Val5,ASN9)-ANGIOTENSIN I; (ASN1,Val5,ASN9) ANGIOTENSIN I SALMON; ASN-Arg-Val-Tyr-Val-HIS-Pro-PHE-ASN-LEU; H-ASN-Arg-Val-Tyr-Val-HIS-Pro-PHE-ASN-LEU-OH |  | C59H87N17O14 | 详情 | 供应商 |
| 104914-40-1 | CYS-GLY-Tyr-GLY-Pro-LYS-LYS-LYS-Arg-LYS-Val-GLY-GLY | CYS-GLY-Tyr-GLY-Pro-LYS-LYS-LYS-Arg-LYS-Val-GLY-GLY; SV40 NUCLEAR TRANSPORT SIGNAL PEPTIDE ANALOG; C-G-Y-G-P-K-K-K-R-K-V-G-G; CYS-GLY-Tyr-GLY-Pro-LYS-LYS-LYS-Arg-LYS-Val-GLY-GLY; H-CYS-GLY-Tyr-GLY-Pro-LYS-LYS-LYS-Arg-LYS-Val-GLY-GLY-OH; cys-gly-Tyr-gly-Pro-lys-lys-lys-Arg-*lys-Val-gly-; CYS-GLY-Tyr-GLY-Pro-LYS-LYS-LYS-Arg-LYS- Val-GLY-GL |  | C60H104N20O15S | 详情 | 供应商 |
| 125093-93-8 | VIP ANTAGONIST | H-LYS-Pro-Arg-Arg-Pro-Tyr-THR-ASP-ASN-Tyr-THR-Arg-LEU-Arg-LYS-GLN-MET-ALA-Val-LYS-LYS-Tyr-LEU-ASN-SE; H-LYS-Pro-Arg-Arg-Pro-Tyr-THR-ASP-ASN-Tyr-THR-Arg-LEU-Arg-LYS-GLN-MET-ALA-Val-LYS-LYS-Tyr-LEU-ASN-SER-ILE-LEU-ASN-NH2; KPRRPYTDNYTRLRKQMAVKKYLNSILN-NH2; VASOACTIVE INTESTINAL PEPTIDE ANTAGONIST; VIP ANTAGONIST; (lys1,Pro2,5,Arg3,4,Tyr6)-vasoactive*intestinal P; (LYS1 Pro2 5 Arg3 4 Tyr6)-VASOACTIVE &; (VIP-neurotensin) hybrid antagonist; H-Lys-Pro-Arg-Arg-Pro-Tyr-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2 |  | C154H257N49O40S | 详情 | 供应商 |
| 89458-24-2 | GLY-PHE-GLN-GLU-ALA-Tyr-Arg-Arg-PHE-Tyr-GLY-Pro-Val | H-GLY-PHE-GLN-GLU-ALA-Tyr-Arg-Arg-PHE-Tyr-GLY-Pro-Val-OH; OSTEOCALCIN, FRAGMENT 37-49; OSTEOCALCIN (37-49) (HUMAN); OSTEOCALCIN, HUMAN (37-49); H-GLY-PHE-GLN-GLU-ALA-Tyr-Arg-Arg-PHE-Tyr-GLY-Pro-Val-OH; GFQEAYRRFYGPV; GLY-Pro-GLN-GLU-ALA-Tyr-Arg-Arg-PHE-Tyr-GLY-Pro-Val; GLY-PHE-GLN-GLU-ALA-Tyr-Arg-Arg-PHE-Tyr-GLY-Pro-Val; BONE GLA ProTEIN, HUMAN (37-49) |  | C75H104N20O19 | 详情 | 供应商 |
